Raking in net proceeds of $57 million, Rigel Pharmaceuticals Inc. more than doubled its cash reserves after pricing a common stock offering. (BioWorld Today)

Raking in net proceeds of $57 million, Rigel Pharmaceuticals Inc. more than doubled its cash reserves after pricing a common stock offering. (BioWorld Today)

Growing product sales boosted earnings at Genzyme Corp., which lived up to analyst expectations with its fourth-quarter financial statement. (BioWorld Today)

Growing product sales boosted earnings at Genzyme Corp., which lived up to analyst expectations with its fourth-quarter financial statement. (BioWorld Today)